under pressure: a review of normal-tension glaucomaunder pressure: a review of normal-tension...
TRANSCRIPT
VOL 74 | NO 4 2012C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I E 33
CLINICAL REVIEW
BY DEREK MACDONALD, OD, FAAO
Introduction
For a disease recognized as a common cause of irreversible
vision loss, a universally agreed--
-1 Primary open-angle glaucoma
--
3
--
4
only pressure-dependent optic neuropathy.5
be abandoned in favour of viewing -
-
Epidemiology and Risk Factors
8
common, more severe, and more
serious disease.11-13 -
Under pressure: a review of normal-tension glaucoma
En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse aura une pression intraoculaire se situant à l’intérieur des limites de la normale et recevra le diagnostic de glaucome à tension normale. Les professionnels des soins oculovisuels (et leurs patients) auront intérêt à bien connaître le diagnostic, le traitement et le pronostic de cette condition et à bien comprendre non seulement les similitudes et les di!érences avec le glaucome primaire à angle ouvert mais les rôles importants joués par le système nerveux central et l’état vasculaire systémique.
Mots clés : Glaucome à tension normale (GTN), glaucome primaire à angle ouvert (GPAO), hystérèse cornéenne (HC), hémorragie discale (HD), atrophie péripapillaire de la zone bêta (APP!), pression de perfusion oculaire (PPO), dysrégulation vasculaire, pression du liquide céphalorachidien (PLCR), di"érence de pression à travers la lame criblée, neuroprotection
RÉSUMÉ
C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I EVOL 74 | NO 4 201234
14 -
-
-
Pathophysiology – Under Pressure
-
-versally.19
-
-
-
-
-
-
31
cc
encompassing a more global corneal
cc
33
-34
35
On average, every third patient with glaucomatous optic neuropathy will present with intraocular pressure within the statistically normal range, manifesting normal-tension glaucoma. Eye care practitioners (and their patients) will bene"t from a familiarity with the diagnosis, treatment, and prognosis of this condition, including similarities to, and di!erences from, primary open-angle glaucoma, and the important roles played by the central nervous system and systemic vascular status.
Key words: normal-tension glaucoma (NTG), primary open-angle glaucoma (POAG), corneal hysteresis (CH), disc hemorrhage (DH), beta-zone peripapillary atrophy (!PPA), ocular perfusion pressure (OPP), vascular dysregulation, cerebrospinal #uid pressure (CSFP), trans-lamina cribrosa pressure di"erential, neuroprotection
ABSTRACT
VOL 74 | NO 4 2012C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I E 35
in generalized poor perfusion. -
decreased vascular perfusion,
demands.38
without cardio-
-
-
8,38
-sion causing low ocular perfusion
39-41
44,45
48,49
without -
-
53
-
-
4,14
-
-
-55
Episodic vaso-
35
-
39
-
58,59
-
C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I EVOL 74 | NO 4 201236
-
-
-
Structural Change
-
migraine.
-
83-88
of migraine.
diagnosis.91
-83
overlooked during clinical exam as -
diagnosis.
VOL 74 | NO 4 2012C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I E 37
loss.
-ing conversion.94
99
Eyes
-
progression.
-
-
-
requiring more aggressive pressure
-
parapapillaryperipapillary
-mal eyes,
Many believe
severe disease. -
-
diagnosis.113-115
large areas of
115
secondary
C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I EVOL 74 | NO 4 201238
114
of
-
Functional Change
118
-
93
year.99
-
119
-
-
measures.
-
Management
-
19
8
low pressures.
-ered.131-134
-135
-
VOL 74 | NO 4 2012C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I E 39
135
-
-
-
-
-19
-
138
139
-
141
-
-
-
C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I EVOL 74 | NO 4 201240
Conclusion
-
--
References
Arch Ophthalmol
Can J Ophthalmol
Arch Ophthalmol
Can J Ophthalmol
Arch Ophthalmol
glaucoma. Arch Ophthalmol
Br J Ophthalmol
glaucoma. Am J Ophthalmol
Ophthalmol
Br J Ophthalmol
angle glaucoma? Curr Opin Ophthalmol
Am J Ophthalmol
glaucoma under ß-blocker Acta Ophthalmol
primary open angle glaucoma versus
Curr Eye Research
glaucoma. J Glaucoma
Open Ophthalmol J
Mol Vis
PLoS Genetics
progression. Arch Ophthalmol
Curr Opin Ophthalmol
Invest Ophthalmol Vis Sci
lens sensor. Arch Ophthalmol
Acta Ophthalmol Scand
Arch Ophthalmol
differences in glaucoma: prevalence, Curr Opin
Ophthalmol
and prevalence of primary open-angle glaucoma. J Nat Med Assoc
Arch Ophthalmol
Arch Ophthalmol
Eye
of glaucoma. Curr Opin Ophthalmol
VOL 74 | NO 4 2012C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I E 41
This case encapsulates the diagnostic dilemma of NTG.The patient in question is a 51-year old myopic (-7.00D) Asian female who discontinued treatment with prostaglandin analog two years ago. She takes no systemic medications, and denies any symptoms of sys-temic vascular dysregulation. Her IOPs are 14 and 15mmHg; her CCTs are 494 and 493 microns.The right ONH (top photo) is obliquely inserted, with superior temporal DH, inferior temporal #PPA, and adjacent RNFL defect. The left ONH shows inferior temporal NRR thinning with adjacent RNFL defect. Initial VF analysis (albeit with questionable reliability; con"rma-tion pending) shows an early supe-rior nasal step in both right and left. Her GP is being consulted to ensure that her systemic vascular status is satisfactory. Pending con"rmatory VF analyses, topical treatment with prostaglandin analog (with a target pressure approaching the episcleral venous pressure of ~10mmHg) is likely to be initiated.
RIGHT EYEFIXATION LOSSES: 0/13FALSE POS ERRORS: 9%FALSE NEG ERRORS: 4%TEST DURATION: 03:28
Appendix – Illustrative Case Presentation
LEFT EYEFIXATION LOSSES: 5/12 xxFALSE POS ERRORS: 18% xxFALSE NEG ERRORS: 11%TEST DURATION: 03:45
EXCESSIVE HIGH FALSE POSITIVES***
GHTOUTSIDE NORMAL LIMITSVFI 97%MD –0.03 dBPSD 2.30 dB P<5%
GHTOUTSIDE NORMAL LIMITSVFI 97%MD –0.98 dBPSD 2.67 dB P<2%
C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I EVOL 74 | NO 4 201242
J Glaucoma
Am J Ophthalmol
open-angle glaucoma. BMC Ophthalmol
glaucoma. J Glaucoma
Prog Ret Eye Research
glaucoma. Ophthalmol
pressure in glaucoma. Clin Exp Optom
Clin Ophthalmol
Arch Ophthalmol
Ophthalmologica
in glaucoma: a review. Clin Experiment Ophthalmol
angle glaucoma. Can J Ophthalmol
Ophthalmol
pressure, perfusion pressure, and glaucoma. Am J Ophthalmol
Invest Ophthalmol Vis Sci
Blood Pressure
Jpn J Ophthalmol
glaucoma. Arch Ophthalmol
Am J Ophthalmol
progression. Invest Ophthalmol Vis Sci
Invest Ophthalmol Vis Sci
in glaucoma. Expert Rev Ophthalmol
J Human Hypertension
Can J Ophthalmol
Arch Ophthalmol
glaucoma. Br J Ophthalmol
Br J Ophthalmol
glaucoma. Acta Ophthalmol
of primary open-angle glaucoma? Ophthalmol
Medical Hypotheses
pressure in glaucoma. Ophthalmol
Acta Ophthalmol
in primary open angle glaucoma,
Invest Ophthalmol Vis Sci
pressure is decreased in primary open-angle glaucoma. Ophthalmol
in glaucoma? Medical Hypotheses
Br J Ophthalmol
BMC Neurology
Ophthalmol
VOL 74 | NO 4 2012C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I E 43
Arch Ophthalmol
Asian J Ophthalmol
Optom Vis Sci
Arch Ophthalmol
Arch Ophthalmol
Invest Ophthalmol Vis Sci
Ophthalmol
glaucomas. Surv Ophthalmol
glaucoma. Ophthalmol
Graefes Arch Clin Exp Ophthalmol
pressure. Arch Ophthalmol5.
Invest Ophthalmol Vis Sci
J Glaucoma
Am J Ophthalmol
Ophthalmol
Ophthalmol
Arch Ophthalmol
Br J Ophthalmol
HKI Ophthalmol
glaucoma and primary open-angle glaucoma. Clin Experiment Ophthalmol
Eye
Arch Ophthalmol
Clin Experiment Ophthalmol
Am J Ophthalmol
loss in progressive glaucoma. Arch Ophthalmol
Arch Ophthalmol
Am J Ophthalmol
glaucoma. Arch Ophthalmol
Arch Ophthalmol
Am J Ophthalmol
Ophthalmol
PLoS ONE
J Glaucoma
Ophthalmol
Arch Ophthalmol
Am J Ophthalmol
glaucoma eyes. Invest Ophthalmol Vis Sci
Ophthalmol
progression. Ophthalmol
C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I EVOL 74 | NO 4 201244
myopia. Ophthalmol
Graefes Arch Clin Exp Ophthalmol
glaucoma. Ophthalmol
for glaucoma progression: disc
Asia-Pac J Ophthalmol
pressure glaucoma. Am J Ophthalmol
Ophthalmol
glaucoma. Clin Ophthalmol
Ophthalmol Vis Sci
glaucoma eyes. Invest Ophthalmol Vis Sci
angle glaucoma. Asian J Ophthalmol
Am J Ophthalmol
Ophthalmol
Arch Ophthalmol
Invest Ophthalmol Vis Sci
Graefes Arch Clin Exp Ophthalmo81.
J Glaucoma
Br J Ophthalmol
Invest Ophthalmol Vis Sci
J Glaucoma
Ophthalmol
Ophthalmol
pressure and glaucoma progression. Arch Ophthalmol
Ophthalmol
Ophthalmol
newly diagnosed open-angle glaucoma. Arch Ophthalmol
Arch Ophthalmol
Am J Ophthalmol
Surv Ophthalmol
Ophthalmol
dorzolamide. BMC Ophthalmol
BMC Ophthalmol
for glaucoma? Arch Ophthalmol
Ophthalmol
Can J Ophthalmol
in glaucoma. Am J Ophthalmol
Clin Ophthalmol